Active Ingredient(s):Osilodrostat Phosphate FDA Approved: * March 6, 2020 Pharm Company: *RECORDATI RARE Category:Genetic Disorders
Osilodrostat, sold under the brand name Isturisa, is a medication for the treatment of adults with Cushing's disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease. It is taken by mouth.
The most common side effects are adrenal insufficiency, headache, vomiting, nausea, fatigue, and edema (swelling caused by fluid retention).
Hypocortisolism (low cortisol lev...
* May have multiple approval dates, manufacturers, or labelers.